TE, H., EK, K., J, L., D, G., JJ, K., & V, K. (2024). Genetic evidence for efficacy of targeting IL-2, IL-6 and TYK2 signalling in the prevention of type 1 diabetes: A Mendelian randomisation study. Diabetologia, 67(12), 2667. https://doi.org/10.1007/s00125-024-06267-5
Chicago Style (17th ed.) CitationTE, Heikkilä, Kaiser EK, Lin J, Gill D, Koskenniemi JJ, and Karhunen V. "Genetic Evidence for Efficacy of Targeting IL-2, IL-6 and TYK2 Signalling in the Prevention of Type 1 Diabetes: A Mendelian Randomisation Study." Diabetologia 67, no. 12 (2024): 2667. https://doi.org/10.1007/s00125-024-06267-5.
MLA (9th ed.) CitationTE, Heikkilä, et al. "Genetic Evidence for Efficacy of Targeting IL-2, IL-6 and TYK2 Signalling in the Prevention of Type 1 Diabetes: A Mendelian Randomisation Study." Diabetologia, vol. 67, no. 12, 2024, p. 2667, https://doi.org/10.1007/s00125-024-06267-5.